Azithromycin
| Igoa oloa | AZithROMYCIN | ||
| CAS | 83905-01-5 | ||
| HS CODE | 29419090 | ||
| Faaiʻu | 5 tausaga | ||
| Tulaga faatonuina | EP o iai nei | ||
| Foliga Vaaia | Paʻepaʻe pe toeititi papaʻe paʻepaʻe crystalline | ||
| Solubility | E masani ona le mafai ona tuiina i le vai, e mafai foʻi ona soluble i le ethanol anhydrous ma le inmethylene chloride | ||
| Faʻailoaina IR | O gatasi ma Azithromycin RSS e tatau ona manino ma leai se lanu .I le va o le 9.0 ma le l1.0I le va o le -45 ma le -49 | ||
| Fesoasoani vailaʻau | Le mama L | ≤0.5% | |
| Le mama M | ≤0.5% | ||
| Le mama E | ≤0.5% | ||
| Le mama F | ≤0.5% | ||
| Le mama D ma J | ≤0.5% | ||
| Le mama I | ≤0.5% | ||
| Le mama C | ≤0.5% | ||
| Le mama N | ≤0.5% | ||
| Le mama H | ≤0.5% | ||
| Le mama A | ≤0.5% | ||
| Le mama P. | ≤0.5% | ||
| Le mama O | ≤0.5% | ||
| Le mama G | ≤0.2% | ||
| Le mama B | ≤2.0% | ||
| Soʻo se isi lava mea le mama | ≤0.2% | ||
| Aofai o mea le mama | ≤3.0% | ||
| Uamea mamafa s | ≤25ppm | ||
| Vai | 1.8% -6.8% | ||
| Lefulefu Sulphated | ≤0.2% | ||
| Taumafai I luga o le anhydrous faavae | 98,3% | ||
| Faʻavaʻa solvents | Acetone | ≤3200ppm | |
| Metanolilo | 0003000ppm | ||
| Dichloromethane | ≤600ppm | ||
| Lapoʻa tele | 0.35 ~ 0.65g / ml | ||
| Maualuga faʻapipiʻi | 0.65 ~ 0.85g / ml | ||
| Tufatufa tele lapisi | ≥80% 40mesh | ||
| gaioiga | O le Carvedilol e malosi lona fatu ma aʻafiaga o le neuroprotective: e le pei o le masani β-receptor antagonists, o le faʻaaoga umi o lenei oloa i tagata mamaʻi e le gata e mafai ai ona faʻalauteleina vaʻaia ma fatugaʻo vaʻa, faʻaititia vafeagai teteega, ae faʻaititia foʻi le faʻataʻamilosaga. Ma tetee teteʻe pulmonary, lelei pulea maualuga toto maualuga. Lenei oloa ei ai se aafiaga puipuia i gaioiga fatugao, e le suia renal toto tafe, ae faaititia microalbuminuria, faaitiitia Fatugao tetee tetee, ma ei ai se lelei tulafono faatonutonu aafiaga i le toto lipids. | ||
Tusi lau feʻau ii ma lafo mai ia matou
